Skip to main content
. 2022 Apr 21;58(5):571. doi: 10.3390/medicina58050571

Figure 2.

Figure 2

Potential mechanisms underlying the antihyperglycemic actions exerted by targeted synthetic DMARDs (tsDMARDs). * Studies conducted in mice (baricitinib) and rats (tofacitinib). Abbreviations: CXCL9, C-X-C motif chemokine ligand 9; CXCL10, C-X-C motif chemokine ligand 10; DMARDs, disease-modifying antirheumatic drugs; IFN-γ, interferon-γ; IL, interleukin; SAA, serum amyloid A; TNF-α, tumor necrosis factor α.